The Apex Times
Above the Noise
Business Wire
BusinessApple’s forward P/E around 33.5X keeps investors debating valuation as growth drivers compete with macro headwindsThe Apex TimesBusinessBMO flags more upside for NVIDIA, even after NVDA’s surgeThe Apex TimesBusinessNvidia edges lower as it deepens push to address AI’s power-and-infrastructure constraintThe Apex TimesBusinessArk Invest reported holding about $1.16 billion of Tesla stock at the end of the second quarter, underscoring a widening performance gap versus other mega-cap winnersThe Apex TimesBusinessTesla shares rise 3.6% as investors weigh potential momentum from Semi and robotaxi plansThe Apex TimesBusinessWalmart shares extend losses after steep selloff, as Bank of America and JPMorgan urge investors to look through the dropThe Apex TimesBusinessTarga’s long-term ExxonMobil ties could keep Permian buildout rolling, but 2026 spending raises execution pressureThe Apex TimesBusinessCoinbase shares jump after CEO comments on a Washington bill, while peers slideThe Apex TimesBusinessBoeing’s delivery rebound is real, but cash generation is still lagging expectationsThe Apex TimesBusiness11th Circuit vacates DOT order that would have ended Delta and Aeromexico joint ventureThe Apex TimesBusinessJensen Huang points to Marvell as the “next trillion-dollar company,” fueling fresh debate on AI chip market winnersThe Apex TimesBusinessDutch privacy watchdog fines Uber €825 million over automated driver suspensionsThe Apex TimesBusinessApple’s forward P/E around 33.5X keeps investors debating valuation as growth drivers compete with macro headwindsThe Apex TimesBusinessBMO flags more upside for NVIDIA, even after NVDA’s surgeThe Apex TimesBusinessNvidia edges lower as it deepens push to address AI’s power-and-infrastructure constraintThe Apex TimesBusinessArk Invest reported holding about $1.16 billion of Tesla stock at the end of the second quarter, underscoring a widening performance gap versus other mega-cap winnersThe Apex TimesBusinessTesla shares rise 3.6% as investors weigh potential momentum from Semi and robotaxi plansThe Apex TimesBusinessWalmart shares extend losses after steep selloff, as Bank of America and JPMorgan urge investors to look through the dropThe Apex TimesBusinessTarga’s long-term ExxonMobil ties could keep Permian buildout rolling, but 2026 spending raises execution pressureThe Apex TimesBusinessCoinbase shares jump after CEO comments on a Washington bill, while peers slideThe Apex TimesBusinessBoeing’s delivery rebound is real, but cash generation is still lagging expectationsThe Apex TimesBusiness11th Circuit vacates DOT order that would have ended Delta and Aeromexico joint ventureThe Apex TimesBusinessJensen Huang points to Marvell as the “next trillion-dollar company,” fueling fresh debate on AI chip market winnersThe Apex TimesBusinessDutch privacy watchdog fines Uber €825 million over automated driver suspensionsThe Apex TimesBusinessApple’s forward P/E around 33.5X keeps investors debating valuation as growth drivers compete with macro headwindsThe Apex TimesBusinessBMO flags more upside for NVIDIA, even after NVDA’s surgeThe Apex TimesBusinessNvidia edges lower as it deepens push to address AI’s power-and-infrastructure constraintThe Apex TimesBusinessArk Invest reported holding about $1.16 billion of Tesla stock at the end of the second quarter, underscoring a widening performance gap versus other mega-cap winnersThe Apex TimesBusinessTesla shares rise 3.6% as investors weigh potential momentum from Semi and robotaxi plansThe Apex TimesBusinessWalmart shares extend losses after steep selloff, as Bank of America and JPMorgan urge investors to look through the dropThe Apex TimesBusinessTarga’s long-term ExxonMobil ties could keep Permian buildout rolling, but 2026 spending raises execution pressureThe Apex TimesBusinessCoinbase shares jump after CEO comments on a Washington bill, while peers slideThe Apex TimesBusinessBoeing’s delivery rebound is real, but cash generation is still lagging expectationsThe Apex TimesBusiness11th Circuit vacates DOT order that would have ended Delta and Aeromexico joint ventureThe Apex TimesBusinessJensen Huang points to Marvell as the “next trillion-dollar company,” fueling fresh debate on AI chip market winnersThe Apex TimesBusinessDutch privacy watchdog fines Uber €825 million over automated driver suspensionsThe Apex TimesBusinessApple’s forward P/E around 33.5X keeps investors debating valuation as growth drivers compete with macro headwindsThe Apex TimesBusinessBMO flags more upside for NVIDIA, even after NVDA’s surgeThe Apex TimesBusinessNvidia edges lower as it deepens push to address AI’s power-and-infrastructure constraintThe Apex TimesBusinessArk Invest reported holding about $1.16 billion of Tesla stock at the end of the second quarter, underscoring a widening performance gap versus other mega-cap winnersThe Apex TimesBusinessTesla shares rise 3.6% as investors weigh potential momentum from Semi and robotaxi plansThe Apex TimesBusinessWalmart shares extend losses after steep selloff, as Bank of America and JPMorgan urge investors to look through the dropThe Apex TimesBusinessTarga’s long-term ExxonMobil ties could keep Permian buildout rolling, but 2026 spending raises execution pressureThe Apex TimesBusinessCoinbase shares jump after CEO comments on a Washington bill, while peers slideThe Apex TimesBusinessBoeing’s delivery rebound is real, but cash generation is still lagging expectationsThe Apex TimesBusiness11th Circuit vacates DOT order that would have ended Delta and Aeromexico joint ventureThe Apex TimesBusinessJensen Huang points to Marvell as the “next trillion-dollar company,” fueling fresh debate on AI chip market winnersThe Apex TimesBusinessDutch privacy watchdog fines Uber €825 million over automated driver suspensionsThe Apex Times
Back to front
Johnson & Johnson gets FDA 510(k) clearance for updated MONARCH QUEST 3 system
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 21, 1:13 PM EDT

Johnson & Johnson gets FDA 510(k) clearance for updated MONARCH QUEST 3 system

The company’s update to its robotic bronchoscopy platform cleared the FDA through the 510(k) pathway, adding AI-assisted planning and navigation plus upgrades aimed at improving imaging used during lung procedure guidance.

3 min readEditor-approved Apex article

Johnson & Johnson said it has received FDA 510(k) clearance for an update to its MONARCH QUEST 3 robotic bronchoscopy system, a step that expands the regulatory authorization for the company’s platform used to guide procedures inside the lung. The announcement comes as medical device makers increasingly look to software and AI capabilities to improve how clinicians plan and execute complex procedures.

The cleared MONARCH QUEST 3 update centers on enhancements to how the system helps clinicians plan, navigate, and visualize airways during bronchoscopy. According to the report, the update includes AI-powered functions designed to support procedure planning and navigation, and it also introduces upgrades related to imaging. In practical terms, those changes are aimed at improving the quality of guidance a physician receives in real time as the device is used to reach targeted areas within the bronchial tree.

The FDA 510(k) process is a regulatory pathway in which a device is reviewed to confirm it is substantially equivalent to a legally marketed predicate device, rather than requiring the same type of premarket approval that is used for certain higher-risk products. By clearing the update under 510(k), J&J is indicating that regulators view the changes as meeting the standards for safety and effectiveness based on the device category and comparison approach.

J&J did not, in the cited post, break out granular details such as the specific imaging improvements’ technical specifications, which AI functions are included, or whether the update applies to particular clinical use-cases, indications, or procedural steps within bronchoscopy. The report also does not specify whether the clearance changes labeling language, training requirements, or deployment timelines for customers already using the system.

MONARCH QUEST systems are positioned in the market for robotic bronchoscopy, where navigation and visualization are intended to help clinicians reach targets in the lung using image guidance and robotic-assisted control. The added emphasis on AI in this update reflects a broader industry trend in which device manufacturers try to translate software capabilities into workflow improvements, with the goal of making it easier for clinicians to plan access routes and maintain orientation while performing minimally invasive procedures.

For J&J, additional regulatory clearances can matter operationally even when the underlying device platform is already deployed, because updates often affect how customers evaluate the product. Software-and-imaging upgrades can also influence adoption decisions for hospitals that weigh performance improvements, physician training considerations, and the administrative work required to support new system configurations.

It is also notable that the report frames the update as an incremental advancement rather than a completely new platform, which may mean the company is building on an already cleared ecosystem. That matters in the bronchoscopy market, where procurement decisions may depend on continuity, interoperability, and how quickly clinical teams can incorporate new guidance features into everyday practice.

What remains unclear is the extent to which the AI features are tailored to specific imaging inputs, whether there are performance benchmarks disclosed for the new planning and navigation functions, and how the update will be positioned versus other robotic navigation and visualization systems on the market. The cited post does not provide clinical study results or reimbursement impact, so investors and customers will likely need to look for later documentation, labeling updates, or additional disclosures from the company.

Why It Matters

  • FDA clearance allows J&J to move forward with the updated system in markets where the 510(k) clearance applies, supporting ongoing adoption of the MONARCH QUEST 3 platform.
  • By emphasizing AI-enabled planning and navigation, J&J is aligning its product roadmap with demand for software-driven improvements in procedural guidance.
  • Imaging upgrades can be a differentiator in robotic bronchoscopy, where clinicians rely on visualization to guide access to targets.
  • Limited disclosure around performance metrics and labeling specifics means the real-world impact will likely depend on later technical documentation and clinical feedback.

Sources

Key Facts

  • Johnson & Johnson received FDA 510(k) clearance for an update to its MONARCH QUEST 3 robotic bronchoscopy system.
  • The update adds AI-powered planning and navigation capabilities for the procedure guidance workflow, according to the report.
  • The update also includes imaging-related upgrades intended to improve visualization during bronchoscopy, per the report.
  • The 510(k) pathway is based on demonstrating substantial equivalence to a predicate device rather than using the premarket approval pathway for higher-risk products.
  • The cited report does not provide detailed technical specifications, specific clinical indications, or labeling changes associated with the cleared update.

Healthcare Related